Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Cancer
|
December 18, 2001
Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of care
B K Link, G T Budd, S Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1995
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study
G T Budd, S Green, R M O'Bryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects
R M Bukowski, G T Budd, J A Gibbons, et al.
Investigational New Drugs
|
August 25, 2000
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas
T Chidiac, G T Budd, R Pelley, et al.
Cancer Research
|
February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancy
R M Bukowski, J S Sergi, W J Sharfman, et al.
American Journal of Clinical Oncology
|
June 11, 1999
Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer
D J Adelstein, T W Rice, L A Rybicki, et al.
Cancer Treatment Reports
|
December 1, 1986
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study
R B Livingston, S Schulman, J G Mira, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy
T Olencki, J Finke, R Tubbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer
G T Budd, P C Adamson, M Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy
R M Bukowski, P Rayman, R Uzzo, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Cancer
|
December 18, 2001
Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of care
B K Link, G T Budd, S Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1995
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study
G T Budd, S Green, R M O'Bryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects
R M Bukowski, G T Budd, J A Gibbons, et al.
Investigational New Drugs
|
August 25, 2000
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas
T Chidiac, G T Budd, R Pelley, et al.
Cancer Research
|
February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancy
R M Bukowski, J S Sergi, W J Sharfman, et al.
American Journal of Clinical Oncology
|
June 11, 1999
Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer
D J Adelstein, T W Rice, L A Rybicki, et al.
Cancer Treatment Reports
|
December 1, 1986
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study
R B Livingston, S Schulman, J G Mira, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy
T Olencki, J Finke, R Tubbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer
G T Budd, P C Adamson, M Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy
R M Bukowski, P Rayman, R Uzzo, et al.
Page
of 7